EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
EIGR
Delisted
EIGR was delisted on the 10th of April, 2024.
71 hedge funds and large institutions have $22.2M invested in Eiger BioPharmaceuticals, Inc. in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
Holders
71
Holding in Top 10
–
Calls
$105K
Puts
$14K
Top Buyers
| 1 | +$2.32M | |
| 2 | +$986K | |
| 3 | +$749K | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$379K |
| 5 |
Renaissance Technologies
New York
|
+$144K |
Top Sellers
| 1 | -$1.42M | |
| 2 | -$747K | |
| 3 | -$678K | |
| 4 |
Millennium Management
New York
|
-$655K |
| 5 |
PAWC
P.A.W. Capital
Greenwich,
Connecticut
|
-$295K |